Position in AMGN
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$35,232,465
+$8,372,940 QoQ
Shares Held
97,295
+27.5% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.98%
of 13F equity value
Holder Rank
#265
of 3,149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Brookstone Capital Management holds $235,547,820 across 12 Drug Manufacturers - General names. AMGN ranks #3 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
65,395 | $78,436,731 | |
| 2 | JNJ |
Johnson & Johnson
|
184,287 | $46,803,369 | |
| 3 | AMGN |
Amgen Inc
This page
|
97,295 | $35,232,465 | |
| 4 | ABBV |
AbbVie Inc.
|
91,033 | $22,907,544 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
144,784 | $18,292,010 | |
| 6 | MRK |
Merck & Co., Inc.
|
130,290 | $16,742,265 | |
| 7 | PFE |
Pfizer Inc
|
272,912 | $6,571,720 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
94,227 | $5,429,359 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,232,465 | 97,295 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $26,859,525 | 76,338 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $24,354,809 | 74,409 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $20,123,964 | 71,311 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $15,431,657 | 55,269 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $15,500,235 | 49,752 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $5,017,841 | 19,252 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $5,732,115 | 17,790 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $5,179,171 | 16,576 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $2,338,816 | 8,226 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $15,581,593 | 54,099 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $16,179,352 | 60,200 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $15,215,252 | 68,531 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $15,666,850 | 64,806 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $1,923,575 | 7,324 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $10,686,890 | 47,413 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $10,714,445 | 44,038 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $7,609,591 | 31,468 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $6,060,016 | 26,937 | Shares | Sole | 2022-01-11 | |
| 2021-09-30 | $1,335,016 | 6,278 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $1,911,243 | 7,841 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $1,176,622 | 4,729 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $1,198,343 | 5,212 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $1,451,507 | 5,711 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $1,027,170 | 4,355 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $1,382,618 | 6,820 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||